Management strategies following recurrence of resected retroperitoneal sarcoma: A 10-year observational study.

Eur J Surg Oncol

Department of Surgery, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK; The Institute of Systems, Molecular and Integrative Biology, The University of Liverpool, Liverpool, UK. Electronic address:

Published: February 2025

Background: In management of retroperitoneal sarcoma (RPS), radical resection remains the main facet of curative treatment. While recurrence is common, a clear consensus does not exist around optimal post-operative surveillance and post recurrence management.

Materials And Methods: Patients undergoing resection for RPS over a 10 year period were identified through a prospectively maintained database. Patients underwent surveillance imaging with intensity dependant on risk of disease recurrence. Rates of recurrence, post recurrence therapeutic modalities and outcomes were recorded.

Results: 105 patients underwent primary resection of RPS in the study period. 5-year survival of patients with low-risk and high-risk of disease recurrence was 74 % and 49 % respectively. Of the 58 patients that suffered disease recurrence, 29 patients with primary recurrence underwent further surgery, 10 patients with oligo-metastatic disease underwent curative intent management and 12 patients underwent chemotherapy (median survival: 6.5 vs 4.0 vs 1.7 years, 5-year survival: 71 % vs 45 % vs 12 %). The cost of surveillance imaging to identify recurrence treated with curative intent was calculated at £5434 and £2269 for low- and high-risk disease respectively.

Conclusions: Post resectional surveillance detects recurrence, allowing further intervention. Such strategies include surgical re-resection, interventional ablation or ablative radiotherapy of oligometastatic disease, and palliative chemotherapy; multifaceted therapeutic options which sit within current management guidelines. Patients with local recurrence who underwent further resection and those who underwent curative-intent management for other metastatic disease had improved outcomes compared to patients with widespread disease recurrence who underwent systemic chemotherapy. The costs of surveillance imaging fit within current UK healthcare economic policy guidelines.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejso.2025.109704DOI Listing

Publication Analysis

Top Keywords

disease recurrence
16
recurrence
13
patients underwent
12
surveillance imaging
12
recurrence underwent
12
patients
10
retroperitoneal sarcoma
8
post recurrence
8
resection rps
8
underwent
8

Similar Publications

Fecal microbiota transplantation for vancomycin-resistant Clostridium innocuum infection in inflammatory bowel disease: A pilot study evaluating safety and clinical and microbiota outcome.

J Microbiol Immunol Infect

March 2025

Chang Gung Microbiota Therapy Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan; Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan; Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan. Electronic address:

Background: Clostridium innocuum is a vancomycin-resistant pathobiome associated with poor clinical outcomes in inflammatory bowel disease (IBD). In ulcerative colitis (UC), it correlates with reduced remission rates, while in Crohn's disease (CD), it is linked to creeping fat formation and intestinal strictures. Notably, some patients experience refractory or recurrent C.

View Article and Find Full Text PDF

Persistence and Recurrence of Primary Hyperparathyroidism.

Best Pract Res Clin Endocrinol Metab

March 2025

Division of Endocrinology and Metabolism, McMaster University, Hamilton, ON, Canada. Electronic address:

Persistent and recurrent primary hyperparathyroidism (PHPT) represent significant challenges in the management of PHPT. Persistent PHPT is defined as persistence of hypercalcemia following parathyroidectomy (PTX) or the recurrence of hypercalcemia within the first 6 months following surgery. Recurrent PHPT is defined as recurrence of hypercalcemia after 6 months following PTX and requires normalization of serum calcium prior to the recurrence.

View Article and Find Full Text PDF

Clinical Effect of Genetic Testing in Inherited Cardiovascular Diseases: A 14-Year Retrospective Study.

J Am Coll Cardiol

March 2025

Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada; Cardiovascular Genetics Centre, Montreal Heart Institute, Montreal, Quebec, Canada. Electronic address:

Background: The clinical impact of genetic testing in a contemporary real-life cohort of patients with heritable cardiomyopathies or arrhythmias is not well defined. Additionally, the genetic spectrum of these conditions in the French-Canadian population is unknown, and interpretation of genetic variants can be challenging because of a known founder effect.

Objectives: This study sought to evaluate the clinical utility of arrhythmia and cardiomyopathy genetic testing and assess the utility of allele frequency data from a local reference population.

View Article and Find Full Text PDF

Kimura disease (KD) is a rare chronic inflammatory condition that primarily affects Asian males and typically presents in the head and neck region. We describe an exceptionally rare case of KD involving the lingual tonsil of Waldeyer's ring in a 39-year-old Japanese man, marking only the second reported instance of lingual involvement and the first specifically affecting the tongue base. The patient presented with a well-circumscribed, 3.

View Article and Find Full Text PDF

The incidence and prevalence of urolithiasis are increasing in industrialized countries. In particular, an increase has been observed among young adults and women. The gender gap is closing, and gender equality (1:1) with regard to urolithiasis has already been documented for the USA.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!